{
    "eid": "2-s2.0-85103342879",
    "title": "STK11/LKB1 mutations in NSCLC are associated with KEAP1/NRF2-dependent radiotherapy resistance targetable by glutaminase inhibition",
    "cover-date": "2021-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Piyada Sitthideatphaiboon",
        "Ana Galan-Cobo",
        "Marcelo V. Negrao",
        "Xiao Qu",
        "Alissa Poteete",
        "Fahao Zhang",
        "Diane D. Liu",
        "Whitney E. Lewis",
        "Haley N. Kemp",
        "Jeff Lewis",
        "Waree Rinsurongkawong",
        "Uma Giri",
        "J. Jack Lee",
        "Jianjun Zhang",
        "Jack A. Roth",
        "Stephen Swisher",
        "John V. Heymach"
    ],
    "citedby-count": 34,
    "ref-count": 50,
    "ref-list": [
        "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Definitive and adjuvant radiotherapy in locally advanced non-small-cell lung cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline",
        "Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancer",
        "Role of KEAP1/NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiation resistance",
        "Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy",
        "Radio-resistance of KRAS/TP53-mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition in vivo",
        "Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer",
        "Radiation resistance in KRAS-mutated lung cancer is enabled by stem-like properties mediated by an osteopontin-EGFR pathway",
        "Comprehensive molecular profiling of lung adenocarcinoma",
        "Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies",
        "Tracking the evolution of non-small-cell lung cancer",
        "Somatic mutations affect key pathways in lung adenocarcinoma",
        "Immunohistochemical loss of LKB1 is a biomarker for more aggressive biology in KRAS-mutant lung adenocarcinoma",
        "Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities",
        "Alterations of LKB1 and KRAS and risk of brain metastasis: comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinoma",
        "LKB1 tumor suppressor protein: PARtaker in cell polarity",
        "Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity",
        "LKB1 and KEAP1/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma",
        "STK11/ LKB1 deficiency promotes neutrophil recruitment and proinflammatory cytokine production to suppress T-cell activity in the lung tumor microenvironment",
        "The LKB1-AMPK pathway: metabolism and growth control in tumour suppression",
        "Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2",
        "An effective strategy for increasing the radiosensitivity of human lung cancer cells by blocking Nrf2-dependent antioxidant responses",
        "Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy",
        "Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance",
        "Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth",
        "LKB1 loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKT",
        "The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer",
        "LKB1 inactivation elicits a redox imbalance to modulate non-small cell lung cancer plasticity and therapeutic response",
        "Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury",
        "Amplification of the g-irradiation-induced cell death pathway by reactive oxygen species in human U937 cells",
        "Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models",
        "RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy",
        "Glutaminase regulation in cancer cells: a druggable chain of events",
        "Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice",
        "Clonogenic assay of cells in vitro",
        "7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: results of a phase 2 clinical trial",
        "STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma",
        "Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer",
        "Oxidative stress in apoptosis and cancer: an update",
        "Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A549 and H460 lung cancer cell lines",
        "Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation",
        "Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC",
        "Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer",
        "Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma",
        "Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer",
        "Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice",
        "Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing",
        "Radiation and the microenvironment - tumorigenesis and therapy",
        "LKB1 promotes radioresistance in esophageal cancer cells exposed to radiation, by suppression of apoptosis and activation of autophagy via the AMPK pathway",
        "Mutant LKB1 confers enhanced radiosensitization in combination with trametinib in KRAS-mutant non-small cell lung cancer"
    ],
    "affiliation": [
        {
            "affiliation-city": "Houston",
            "@id": "60015023",
            "affilname": "The University of Texas MD Anderson Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015023",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Jinan",
            "@id": "60031031",
            "affilname": "Shandong University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031031",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Jane Ford Petrin donation",
        "American Association for Cancer Research",
        "CPRIT",
        "Entertainment Industry Foundation",
        "University of Texas MD Anderson Cancer Center Lung UT",
        "University of Texas Southwestern Medical Center"
    ]
}